CNDP1 and familial pancreatic carcinoma: In order to validate but also to better define the association between reduced CNDP1 levels and prognosis, circulating CNDP1 was determined by SIA in a separate, more homogenous, validation cohort including only subjects with advanced pancreatic cancer (Cohort 2, Table 1 and Fig 1F).